Valeo Pharma Inc is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.
Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.
Symbol | Name | Total Return | Period |
---|
ANRG | Anaergia Inc | -93.778802 | YTD |
HZM | Horizonte Minerals PLC | -93.360996 | YTD |
AUMN | Golden Minerals Co | -92.547945 | YTD |
GBAR | Monarch Mining Corp | -91.666667 | YTD |
LPEN | Loop Energy Inc | -91.428571 | YTD |
MAV | MAV Beauty Brands Inc | -91.111111 | YTD |
TMD | Titan Medical Inc | -90.555556 | YTD |
OPT | Optiva Inc | -85.454545 | YTD |
OREA | Orea Mining Corp | -84.210526 | YTD |
AXIS | Axis Auto Finance Inc | -83.333333 | YTD |
NPK | Verde AgriTech Ltd | -78.787879 | YTD |
SDE | Spartan Delta Corp | -78.461538 | YTD |
IVQ | Invesque Inc | -78.455285 | YTD |
SOT-UN | Slate Office REIT | -77.548611 | YTD |
PEA | Pieridae Energy Ltd | -76.4 | YTD |
IVQ-U | Invesque Inc | -76.373626 | YTD |
CUB | CubicFarm Systems Corp | -75 | YTD |
EXN | Excellon Resources Inc | -75 | YTD |
VPH | Valeo Pharma Inc | -72.807018 | YTD |
NCP | Nickel Creek Platinum Corp | -72.727273 | YTD |
APS | Aptose Biosciences Inc | -71.538459 | YTD |
VRTS | Vertiqal Studios | -71.428571 | YTD |
GENM | Generation Mining Ltd | -71.153846 | YTD |
BU | Burcon NutraScience Corp | -70.12987 | YTD |
WEED | Canopy Growth Corp | -70.063694 | YTD |
All data provided as of December 06, 2023.
More about Valeo Pharma Inc
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Valeo Pharma Inc is listed under VPH on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.